Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01535807 · ClinicalTrials.gov registry record · NA
CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without ECM
A NA study, sponsored by Inova Health Care Services.
- Terminated
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT01535807: Clinical Trial NA study, sponsored by Inova Health Care Services.
NCT01535807 is a NA study that was terminated before completion, run by Inova Health Care Services. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01535807, a NA study, was terminated before completion, sponsored by Inova Health Care Services.
- TERMINATED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The objective of this study is to identify proteomic inflammatory biomarkers to determine if there are differences in the biomarkers in patients who are treated using the CorMatrix ECM implant to close the pericardium and the patients whose pericardium is left open (the current standard of care).
Primary Outcome
Percentage change in Inflammatory Cytokine Levels in serum derived from participant blood sample that underwent novel nanoparticle-based biomarker harvesting technology to capture and isolate global low molecular weight (LMW) proteome. Peptides from captured proteomes are detected with reversed-phase liquid chromatography/electrospray tandem mass spectrometry (LC-MS/MS). Inflammatory cytokines include Interleukin 6 (IL6), Interleukin 8 (IL8), Interleukin 2 Receptor (IL2R), Tumor Necrosis Factor
Interventions
- DEVICE CorMatrix extra cellular matrix (ECM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2012-01 |
| Est. Completion | 2016-06 |
| Phase | NA |
Why NCT01535807 stopped before completion
NCT01535807 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which CorMatrix extra cellular matrix (ECM) is the first listed.
NCT01535807 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01535807 about?
NCT01535807 is a clinical study titled "CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without ECM". The objective of this study is to identify proteomic inflammatory biomarkers to determine if there are differences in the biomarkers in patients who are treated using the CorMatrix ECM implant to close the pericardium and the patients whose pericardium is left open (the current standard of care).
What is the current status of trial NCT01535807?
This trial is currently terminated. It is a NA study. The enrollment target is 44 participants. The study started on 2012-01. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01535807?
The interventions under investigation include: CorMatrix extra cellular matrix (ECM) (DEVICE).
Who is sponsoring clinical trial NCT01535807?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01535807's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia